The use of dexamethasone implant in DME treatment – Safety and efficacy

Poster Details

First Author: K.Michalska-Małecka POLAND

Co Author(s):    M. Sosnowska-Ponska   D. Spiewak                          

Abstract Details


The research aimed to verify efficacy of dexamethasone implant as a possibility of diabetic macular edema treatment. Moreover, on the basis of the prevalence of increased intraocular pressure, the study aimed to determine safety of the treatment.


Professor K. Gibinski University Clinical centre, Medical University of Silesia, Katowice, Poland.


The implant of 700 µg dexamethasone was administered in patients diagnosed with diabetic macular edema. In patients qualified for the treatment ophthalmological examinations were performed: fundus photography, imaging of microvasculature (deep and superficial plexus separately), best corrected visual acuity and intraocular pressure measurement. In all patients the HbA1c test was also carried out. All examinations were performed before as well as 1 day, 14 days and 1 month after the dexamethasone implantation.


Examinations performed after the implantation revealed the improvement in morphological parameters of the retina as well as the reduction of macular edema. In all patients we observed full recovery of best corrected visual acuity.


The research confirmed safety and efficacy of dexamethasone implant as a method of diabetic macular edema treatment.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy